Table 2.
Therapy | Treatment | Mode of Action | References |
---|---|---|---|
Epigenetic Drugs | Zebularine | Reverses SOD2 promoter methylation | [49] |
Tirchostatin A | Regulates histone methylation and acetylation | [51,114] | |
Sodium butyrate | |||
Adenoviral Vectors | Cu-Zn SOD/SOD2 adenoviral vectors combined with BCNU | Induces SOD expression to reduce cancer cell growth and increases survival | [119] |
SOD2 and TRAIL combination | Enhances SOD expression to stimulate cell apoptosis and reduce tumor growth | [120] | |
Topoisomerase inhibitors | Doxorubucin | Reduces cancer growth by binding to the topoisomerase enzymes and block topoisomerases 1 and 2 | [154] |
Topotecan | |||
Redox Cyclin Compounds | Motexafin gadolinium | Induces apoptosis by alteration in mitochondrial membrane potential, depletion of intracellular GSH and increased ROS production. | [155] |
GSH Depleting Agents | Buthionine sulphoximine | Eliminates GSH from the cells by blocking GPx and accumulates ROS production Oxidative inactivation of H-Ras and NF-kB Oxidative damage of mitochondria Induces apoptosis |
[126,127,128,133] |
β-phenylethyl isothiocyanates (PEITC) | |||
SOD2 inhibitors | 2-methoxyestradiol | Blocks both manganese and copper, zinc superoxide dismutases and reduces cancer growth | [156] |
Catalase | 3-amino-1,2,4, triazole | Reduces CAT activity Enhances intracellular H2O2 levels Decreases GPx activity |
[157] |
Anti-fungal Antibiotic | Rapamycin | Inhibits cell proliferation Stimulates apoptosis Blocks mTORC1 and activates Akt to promote chemoresistance |
[129,130,131,132,133,134] |
Proteosome inhibitor | MG132 | Reduces FOXM1 expression to induce apoptosis | [137,138,139] |
Thiazole Antibiotic | siomycin-A | ||
Natural Products | Curcumin | Conserves SOD2 expression Delays bile acid-induced esophageal injury and cancer progression |
[147,148] |
Astaxanthin | Inhibits expression of NF-κB, TNF-α, and IL-8 to induce ROS/reactive nitrogen species scavenging | [149] | |
Ginger | Inhibits oxidative stress and cancer growth by stimulating SOD, CAT, GPx, glutathione-S-transferase, and glutathione reductase activities | [150] | |
Oroxylin A | Induces SOD2 gene expression Inhibits glycolysis Suppresses tumor growth |
[151] | |
Protandim | Stimulates SOD and CAT activities Reduces tumor growth |
[153] |
2-ME: 2-methoxyestradiol; Akt: protein kinase B; BCNU: 1,3-bis(2-chloroenthyl)-1-nitrosurea; CAT: catalase; Cu-Zn: copper–zinc; FOXM1: forkhead box M1; GPx: glutathione peroxidases; GSH: glutathione; IL: interleukin; mTORC1: mammalian target of rapamycin complex 1; NF-kB: nuclear factor-kappa B; PEITC: phenylethyl isothiocyanates; ROS: reactive oxygen species; TNF: tumor necrosis factor; TRAIL: TNF-related apoptosis-inducing ligand.